Lab Medicine Rounds

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Justin Juskewitch, M.D., Ph.D., and Andrew Norgan, M.D., Ph.D., both assistant professors of laboratory medicine and pathology at Mayo Clinic, to talk about informatics for the pathologist.  

Timestamps:

0:00 Intro

00:45 Can you start us off by giving an overview of this latest outbreak of Monkeypox? And also if you could contrast that against Covid-19? 

03:25 What do you think this increase means for our hospital laboratories?

05:44 How can we provide the greatest value to our clinical colleagues and to our patients? 

08:17 I know we sometimes do culture a virus and look at viruses. Is it that testing that some of us have in our laboratories that’s not specific enough, it looks like other viruses, is that why we have other tests that we’re using?

10:00 Do you think that Monkeypox would be similar to Covid-19 where we have home test kits for the virus? 

12:21 Outro

Timestamps:

0:00 Intro

01:32 So for residents who have recently started, now that orientation is behind us, where should their focus be?

09:05 Do you have any advice for what step 1 or 2 might look like for a new resident?

13:46 What is a new skill or two that residents should really focus on developing? 

18:26 Could you share with the student listeners, what do you recommend to residents when they feel like they aren’t making the progress they would like?

23:54 How do you recommend residents approach those meetings with their program director?

28:05 Outro

Timestamps

0:00 Intro
01:10 Why is social media a tool that our lab medicine and pathology community should consider using?
04:01 How do you reassure or talk to a pathology resident or a medical laboratory technologist, who is just getting started on social media, when a patient reaches out with a question?
07:29 What is your advice about how to use your time wisely on social media?
09:57 How do you think about the social media landscape at this point, realizing things are dynamic and changing? How do you characterize and think about these different platforms?
12:10 How has your social media practice evolved over time? What has your journey been like and how has this affected you?
14:48 What skills do you think that you can walk away from this with, what skills have this been helping with for you?
16:44 What is next for you? What challenges do you want to throw out there for the experienced social media person?
17:42 Outro

Timestamps:

0:00 Intro

01:01 What is a patient-scientist? 

01:36 What’s the perspective of value they can bring to the table?

03:57 What has surprised you the most about this experience of being a patient-scientist?

08:05 Since you have shared this, what has been your experience interacting with the research community?

08:57 What are your reflections about how the medical community should understand about developing these relationships, seeking out or welcoming patient scientists in their research, interest or questions?

10:46 What’s been your own experience when you go to patient or research conferences, what is your experience like in those situations given you’re on both sides? 

12:34 Outro

Resources:

TEDx: Researching Your Own Disease

Society of Patient Scientists

Timestamps:

0:00 Intro

00:42 What does the tick season look like this year? Is it true that is has been predicted to be a severe tick season?

01:20 What are the different things that influence the tick season?

03:49 What does “severe tick summer” mean for all of us working and learning in the hospital?

05:08 Have you been getting invitations to talk to some of our clinical colleagues about that differential diagnosis?

05:53 There has been a lot of concern over “superbugs”, are tick-borne diseases evolving as well?

07:30 Going forward, is it going to get worse? What are the experts in the community saying?

09:11 You do a lot of research in the field. I was curious if you have a favorite story about those experiences of leading some students and colleagues into the field to do this tick-based research?

11:48 Outro

Resources:
The Essentials of Ticks and Tick-Borne Diseases

Timestamps:
0:00 Intro
00:46 Why is 3D imaging and printing important for patient care?
03:18 Can you help our audience understand when should we be using this? When is it not so good? 
09:38 How does that conversation go now differently? Now that somebody can hold this, how has that transformed the questions and the understanding that the patient has?
13:05 Can you help us get our arms around what is the value in the scan, what is the print value?
14:01 Technologies for scanning are improving and that’s resulting in better models for you to look at. Is printing of materials being used improving in such a way you can get the same textures?
15:22 How do you see this field really developing? 
17:55 Outro

Timestamps:

0:00 Intro

00:53 Why is the medical field interested in saliva?

02:00 What sorts of information could be gleaned from saliva?

03:17 Are there certain limitations of what could come out of saliva testing?

04:56 Can you elaborate what you mean when you say “matrix?”

06:16 How do you approach navigating what could be interferences?

08:16 Would that be considered part of the matrix? Or is the matrix just the specimen itself?

9:29 Could you elaborate those preanalytic variables a clinician may have top of mind, or what might be in their sphere of control, influence, awareness?

11:41 What’s your advice to laboratory professionals about how we can detect when these kinds of things are going awry, or how do you keep your finger on the pulse of how your colleagues on the clinical side are using your tests?

13:34 What do you see as the future for saliva testing like?

14:54 Outro

Resources: 

https://www.aacc.org/cln/articles/2022/janfeb/saliva-in-the-spotlight 

https://news.mayocliniclabs.com/2022/04/07/darci-block-ph-d-discusses-saliva-testing-in-aaccs-clinical-laboratory-news/ 

Timestamps:
0:00 Intro
00:51 Could you give us an update about what has been happening regarding convalescent plasma?
03:46 What are some take-home points from this new AABB guidelines that are out?
15:07 Were there challenges discussed or things that you see these guidelines either domestically or internationally? 
18:20 Is there an aspect that you would like to see addressed with more robust data as we go forward?
20:12 Outro

Resources:
AABB Guidelines

https://www.aabb.org/news-resources/news/article/2022/04/13/aabb-expert-panel-updates-guidelines-for-clinical-ccp-use

Timestamps:

0:00 Intro

01:15 What has your experience been seeing minorities in Biomedical leadership roles?

03:56 At what points so far have you really been most engaged with leadership training, so that you’re set up for great things in the future? What have you found that really engages/resonates with you?

08:07 Is there one or two insights for what is helpful to make it work, and is there a good first and second step for launching something similar (mentorship program) at their place? 

10:10 Is there something I should do automatically when I have a mentee come in who comes from an underrepresented minority or from a disadvantaged background? Do you recommend that being part of an initial conversation of, “Would you like me to identify a mentor for you?” from a diversity perspective?

12:27 What advice would you like to share with the underrepresented minority student trainee learners who are listening to this podcast? 

14:40 Outro